Isracann Receives Project Characterization Report and Engages EU GMP Consultancy
January 09, 2020 00:05 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a...
Isracann Advances Cannabis Project Characterization in Israel
December 05, 2019 00:05 ET
|
Isracann Biosciences Inc.
--Early reports already impacting decisions resultingin projected process efficiencies and cost savings VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. ...
Isracann Biosciences Hires Expert Consultancy LinC to Steer Israeli Cannabis Project
November 14, 2019 00:01 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a...